View Document Preview and Link Document Date: 2013-07-21 04:57:09 Open Document File Size: 421,32 KB Share Result on Facebook
City London / / Company Therapeutic Subgroup / ADP / EWP Therapeutic Subgroup / CVS / EWP PK Group / / Country United Kingdom / / / Facility Migrating Myoelectric Complex / Canary Wharf / / IndustryTerm food composition / subgroup / food effect / chemical-pharmaceutical data / food-drug interaction / active pharmaceutical ingredient / chemical instability / reference product / food intake influence / generic product / marked food-effect / study protocol / drug-product / immediate release product / chemical entity / food-interaction studies / reference products / food interaction / food study results / food effect studies / food effects / food interactions / generic products / to-be-market product / potential food effect / marked food effect / food interaction study / food / / MedicalCondition CMD / / Organization Pharmacokinetics Working Party EMA / European Medicines Agency / Efficacy Working Party / fed / US Federal Reserve / Pharmacokinetics Working Party / European Union / E-mail info@ema.europa.eu Website www.ema.europa.eu An / IR / Committee for Human Medicinal Products / Background In / / / Position General / / Product clopidogrel / sorbitol / Plavix / omeprazole / losartan / / Technology study protocol / pharmacokinetics / API / drug development / / URL www.ema.europa.eu / / SocialTag 
PKWP (prev EWP-PK) subgroup Position Papers on specific questions